Aenova Group

Aenova Group, founded in 2008, is a leading global B2B service provider in the pharmaceutical and healthcare industries. The company specializes in the comprehensive development and production of medicines and dietary supplements, covering all major dosage forms. With a planned turnover of approximately EUR 750 million, Aenova Group offers end-to-end services, including contract manufacturing and development, and is the European market leader in its field. Its commitment to quality, innovative technologies, and a clear future vision underpins its success in producing active pharmaceutical ingredients (APIs) and finished dosage forms.

The company operates an extensive global network, comprising 29 sites across eleven countries. This international presence supports its mission to deliver complex pharmaceutical solutions efficiently. Aenova Group's success is driven by its workforce of over 4700 employees, who bring diverse expertise to the organization. You can Meet Aenova Group's team to understand the people behind its operations. The company's employee range is 1,000-5,000 employees, reflecting its substantial operational capacity and ability to manage large-scale projects.

Aenova Group reports a revenue of $445.1M, underscoring its significant market presence. Its product portfolio includes capsules, soft gelatine capsules, and nutraceuticals, serving diverse sectors from consumer health to animal health. The company's strategic focus on digital transformation and supply chain management within the pharmaceutical sector ensures continued innovation and operational excellence. Aenova Group's dedication to end-to-end services and its skilled workforce position it for sustained growth and leadership in the competitive healthcare landscape.